You searched for metabolic diseases - Page 27 of 63

glucagon zealand pharma diabetes insulin immunotherapy

News and Trends 20 May 2022

Zealand Pharma’s drug for rare metabolic disease smashes phase III

…been diazoxide, which can’t benefit all patients and can cause side effects including nausea and high blood sugar. “As with many other rare diseases, CHI only recently started to get…

May 20, 2022 - 4 minutesmins - By Jonathan Smith

News and Trends 10 Nov 2022

SOTIO reveal potential treatment for adults with solid tumors at SITC meeting

…cell, BOXR1030, as a potential clinical treatment for the 90% of adult cancer patients with solid tumors. SOTIO: strong clinical path “The GOT2 infused CAR-T cell therapy improved metabolic fitness,…

November 10, 2022 - 4 minutesmins - By Liza Laws

News and Trends 21 Dec 2018

French Scientists Find a Weak Spot in HIV-Infected Cells

…the French scientists unveiled that HIV prefers to infect those T cells with higher metabolic activity, making them a promising target to get rid of the latent virus. T cells…

December 21, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

In Depth 25 Jul 2023

New weight loss drugs: biotech’s mission to end obesity

…manner, enhancing its natural barrier properties. This enhanced mucus barrier results in a pharmacologic ‘duodenal exclusion’ that may non-invasively and safely reproduce many of the beneficial effects of metabolic surgery,…

July 25, 2023 - 8 minutesmins - By Willow Shah-Neville

Best in Biotech 26 Mar 2024

9 biotech companies leading the way in Denmark

…oncology and rare diseases involving endocrinology. In 2021, it had its first product approved by the U.S. Food and Drug Administration (FDA), named SKYTROFA, which is a treatment for pediatric…

March 26, 2024 - 11 minutesmins - By Willow Shah-Neville

In Depth 14 May 2018

Could Stem Cells Replace Animal Testing in Drug Development?

…an answer to this dilemma as well. There are already iPS cell models available for multiple genetic diseases, including neurological disorders like Parkinson’s as well as blood diseases, cardiac syndromes,…

May 14, 2018 - 6 minutesmins - By Timothé Cynober

News and Trends 31 Jan 2017

New British Biotech-Academia Alliance takes on Cardiovascular Disease

Heptares Therapeutics and the University of Cambridge have partnered to investigate a novel target for cardiovascular diseases. Heptares Therapeutics, based in London, develops drugs against historically undruggable G protein-coupled receptors…

January 31, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

alchemyrefiner alchemymagic 3 04e4a427 d1fa 4258 9dab 2690330368fd 0

Podcast 19 Apr 2024

The biotech investment landscape in 2024

…disease areas and look across therapeutic areas. So these days we’re very excited about metabolic and obesity and some of the adjacencies like liver diseases,” she explained. Data and disruption:…

April 19, 2024 - 8 minutesmins - By Jim Cornall

In Depth 11 Dec 2024

Targeting sugar molecules: Can glycobiology lead to a new era for cancer immunotherapy?

…also contribute to immune dysfunction in inflammatory and autoimmune diseases, and targeting sialoglycans and/or their receptors could have therapeutic potential in suppressing the immune system in these diseases. In addition,…

December 11, 2024 - 9 minutesmins - By Willow Shah-Neville

News and Trends 11 Jan 2018

German Biotech Gets FDA Approval to Start an Ulcerative Colitis Phase II Study

…II trials for both ulcerative colitis and Crohn’s disease (CD). Dihydroorotatede hydrogenase (DHODH) inhibition causes metabolic stress in active immune cells, leading to their altered function or apoptosis. With diseases…

January 11, 2018 - 3 minutesmins - By Alex Dale

Best in Biotech 16 Jan 2024

Five biotech companies taking Florida by storm

…drive the state’s biotech scene. Table of contents AIM ImmunoTech AIM ImmunoTech is focused on researching and developing therapies to treat multiple types of cancers, immune disorders, and viral diseases….

January 16, 2024 - 6 minutesmins - By Willow Shah-Neville

Podcast 1 Mar 2024

The final chapter in genomic medicines?

…company be focusing on diseases of the liver. “Fortunately, we were able to scour the landscape of genetic defects of the liver and determine four or five diseases which are…

March 1, 2024 - 8 minutesmins - By Jim Cornall

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

Zealand Pharma’s drug for rare metabolic disease smashes phase III

SOTIO reveal potential treatment for adults with solid tumors at SITC meeting

French Scientists Find a Weak Spot in HIV-Infected Cells

New weight loss drugs: biotech’s mission to end obesity

9 biotech companies leading the way in Denmark

Could Stem Cells Replace Animal Testing in Drug Development?

New British Biotech-Academia Alliance takes on Cardiovascular Disease

The biotech investment landscape in 2024

Targeting sugar molecules: Can glycobiology lead to a new era for cancer immunotherapy?

German Biotech Gets FDA Approval to Start an Ulcerative Colitis Phase II Study

Five biotech companies taking Florida by storm

The final chapter in genomic medicines?

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!